Buscador de publicaciones

Publicaciones

  • de Lucas, R, Vicente-Villa MA, Richardson, C, Lucas, J, Gillespie-Akar, L, Labrador, LG and Torrelo, A.

    Clinical Unmet Needs and Treatment Patterns of Paediatric Psoriasis Patients: A Real-World Evidence Study in Spain

    ACTAS DERMO-SIFILIOGRAFICAS . 114(5): 382-391.

    [doi:10.1016/j.ad.2023.02.017]

  • Amato, ME, Ricart S, Vicente-Villa MA, Martorell-Sampol L, Armstrong-Moron J, Fernandez-Isern G, Mascaro, JM, Balsells S, Alonso, I, Serrano M and Ortigoza-Escobar JD.

    Coexistence of junctional epidermolysis bullosa, autosomal recessive deafness type 57, and Angelman syndrome: A case report

    clinical case reports . 11(4): . Nº de citas: 1

    [doi:10.1002/ccr3.7275]

  • Colmenero M, Del Boz J, Bernabeu Wittel J, Roé E, Feito-Rodríguez M, Vicente-Villa MA, Martín-Santiago A, Palencia Pérez SI, Azon A, Valdivielso-Ramos M, Torrelo A, Sánchez Moya AI, Campos-Domínguez M, Garnacho-Saucedo G, Azaña Defez JM, Vera Casaño Á, Tercedor-Sánchez J, Alcalá R, González-Enseñat MA, Giacaman A, Hernández-Martin Á, Monserrat García MT, Bauzá A, Domínguez-Cruz J, García-Doval I and Grau-Pérez M.

    Inter- and intra-observer variability in the selection of therapy for infantile hemangiomas among pediatric dermatologists in Spain

    PEDIATRIC DERMATOLOGY . 39(4): 557-562. Nº de citas: 3

    [doi:10.1111/pde.15015]

  • Baselga E, El Hachem M, Diociaiuti A, Carnevale C, Downey C, Roe E, Mascaro P, Neri I, Leuzzi M, Bernabeu-Wittel J, Monserrat-García MT, Ortiz-Prieto A, Torrelo A, Knopfel N, Vercellino N, Manunza F, Oranges T, Bassi A, González-Enseñat MA, Vicente-Villa MA, Gich I and Puig L.

    Sequelae following infantile haemangiomas treated with propranolol

    EUROPEAN JOURNAL OF DERMATOLOGY . 31(6): 785-790. Nº de citas: 6

    [doi:10.1684/ejd.2021.4172]

  • Carrascosa JM, de la Cueva P, de Lucas R, Fonseca E, Martín A, Vicente-Villa MA, Fortes MP, Gómez S and Rebollo FJ.

    Patient Journey in Atopic Dermatitis: The Real-World Scenario

    Dermatology and Therapy . 11(5): 1693-1705. Nº de citas: 7

    [doi:10.1007/s13555-021-00592-y]

  • Cuenca-Barrales C, Baselga E, Del Boz-González J, Vicente-Villa MA, Palencia-Pérez SI, Campos-Domínguez M, Valdivieso-Ramos M, Martín-Santiago A, Montserrat-García MT, Azón-Masoliver A, Feito-Rodríguez M, Domínguez-Cruz JJ, Roé-Crespo E, Salas-Márquez C, Giacaman A, Lorente-Lavirgen AI, Quintana-Castanedo L, de Vega-Martínez M, García-Doval I and Bernabéu-Wittel J.

    Baseline Description of the Spanish Academy of Dermatology Infantile Haemangioma Nationwide Prospective Cohort. Comparison of Patients Treated with Propranolol in Routine Clinical Practice with Previous Pivotal Clinical Trial Data

    ACTAS DERMO-SIFILIOGRAFICAS . 112(9): 806-816. Nº de citas: 3

    [doi:10.1016/j.ad.2021.05.007]

  • Dávila Osorio VL, Vicente-Villa MA, Baselga E, Salvador-Hernandez H, Cruz-Martínez O and Prat-Torres CS.

    Adverse cutaneous effects of mitogen-activated protein kinase inhibitors in children

    PEDIATRIC DERMATOLOGY . 38(2): 420-423. Nº de citas: 8

    [doi:10.1111/pde.14354]

  • Valdivielso-Ramos, M, Martin-Santiago, A, Azana, JM, Hernandez-Nunez, A, Vera, A, Perez, B, Tercedor, J, Feito, M, Vicente-Villa MA, Prat-Torres CS, Lopez-Gutierrez, JC, Garnacho, G, Baselga E, Roe, E, Palencia, S, Cordero, P, Moreno, R, Agudo, A, de la Cueva, P and Torrelo, A.

    Capillary malformation-arteriovenous malformation syndrome: a multicentre study

    CLINICAL AND EXPERIMENTAL DERMATOLOGY . 46(2): 300-305. Nº de citas: 28

    [doi:10.1111/ced.14428]

  • Martín-Nalda A, Fortuny-Guasch C, Rey L, Bunney TD, Alsina L, Esteve-Solé A, Bull D, Anton MC, Basagaña M, Casals F, Deyá A, García-Prat M, Gimeno R, Juan-Otero M, Martinez-Banaclocha H, Martinez-Garcia JJ, Mensa-Vilaró A, Rabionet-Janssen R, Martin-Begue N, Rudilla F, Yagüe-Ribes J, Estivill X, García-Patos V, Pujol RM, Soler-Palacín P, Katan M, Pelegrín P, Colobran R, Vicente-Villa MA and Arostegui-Gorospe JI.

    Severe Autoinflammatory Manifestations and Antibody Deficiency Due to Novel Hypermorphic PLCG2 Mutations

    JOURNAL OF CLINICAL IMMUNOLOGY . 40(7): 987-1000. Nº de citas: 40

    [doi:10.1007/s10875-020-00794-7]

  • Gálvez V, Chacón-Solano E, Bonafont J, Mencía Á, Di WL, Murillas R, Llames S, Vicente-Villa MA, Del Rio M, Carretero M and Larcher F.

    Efficient CRISPR-Cas9-Mediated Gene Ablation in Human Keratinocytes to Recapitulate Genodermatoses: Modeling of Netherton Syndrome

    Molecular Therapy-Methods & Clinical Development . 18: 280-290. Nº de citas: 14

    [doi:10.1016/j.omtm.2020.05.031]